Home » Newsletters » BioWorld Science

BioWorld Science

July 7, 1998

View Archived Issues

Novel flavonoid derivative SU-840 with potent gastroprotective and ulcer-healing effects

Treatment with recombinant IL-1 receptor safe in HIV-infected patients

OPC-14117: tolerability and safety as antioxidant therapy for Huntington's disease

HIV protease inhibitors developed by research group at Sankyo

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

Zeneca forms new subsidiary in Taiwan

Unigene and Warner-Lambert accelerate development of oral calcitonin product

Genta and NCI to collaborate on G-3139 development

Granocyte granted expanded marketing authorization

U.S. patent issues for second product in PathoGenesis' pipeline

Novel antitumor agent discovered by Banyu

Taisho claims potent and selective D4 receptor antagonists

Carcinostatic agents developed at Toagosei

ACAT inhibitors from SS Pharm. for atherosclerosis

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

Series of MMP and TACE inhibitors patented by American Cyanamid

GRP antagonist inhibits pancreatic carcinoma growth in vitro and in vivo

New antimigraine option now available in Canada

Ganaxolone study results presented at AASH meeting

Sankyo overseas clinical pipeline

CNS-selective effects of synthetic, nonfeminizing estrogens

Immunex and American Home Products restructure collaboration

Pasteur Merieux Connaught's AIDS vaccine pipeline in review

Nonsteroidal antiestrogen EM-800 shows potential in breast cancer, osteoporosis

Phase I/II trial of gene therapy to treat peripheral vascular disease

BTG offers paclitaxel analogues for licensing

Phase Ia clinical trial with NIF for ischemic stroke completed by Pfizer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...